Academic Content and Language Evaluation of This Article
CrossCheck and Google Search of This Article
Academic Rules and Norms of This Article
Supplementary Materials of This Article
Citation of this article
Corresponding Author of This Article
Research Domain of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (4427)
All Articles published online
|
Publishing Process of This Article
|
Apr 27, 2022 (publication date) through Nov 22, 2024
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Hepatology
ISSN
1948-5182
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| For: | Apostolov R, Gianatti E, Wong D, Kutaiba N, Gow P, Grossmann M, Sinclair M. Testosterone therapy reduces hepatic steatosis in men with type 2 diabetes and low serum testosterone concentrations. World J Hepatol 2022; 14(4): 754-765 [PMID: 35646271 DOI: 10.4254/wjh.v14.i4.754] |
|---|---|
| URL: | https://www.wjgnet.com/1948-5182/full/v14/i4/754.htm |
| Number | Citing Articles |
| 1 |
Nabil Eid, Payal Bhatnagar, Li-Li Chan, Marina Garcia-Macia. Suppression of hepatic steatosis in non-alcoholic steatohepatitis model by modified Xiaoyao San formula: Evidence, mechanisms and perspective. World Journal of Hepatology 2024; 16(10): 1208-1212 doi: 10.4254/wjh.v16.i10.1208
|
| 2 |
L. J. Yang, J. Z. Zhou, Y. F. Zheng, X. Hu, Z. Y. He, L. J. Du, X. Gu, X. Y. Huang, J. Li, Y. Q. Li, L. Y. Pan, X. X. Zhang, X. J. Gu. Association of non-alcoholic fatty liver disease with total testosterone in non-overweight/obese men with type 2 diabetes mellitus. Journal of Endocrinological Investigation 2023; 46(8): 1565 doi: 10.1007/s40618-023-02006-6
|
| 3 |
Adrian M Gonzalez-Gil, Yoann Barnouin, Alessandra Celli, Viola Viola, Marcos D Villarreal, Maria Liza Duremdes Nava, Adam Sciuk, Clifford Qualls, Reina Armamento-Villareal, Dennis T Villareal. Metabolic Effects of Testosterone Added to Intensive Lifestyle Intervention in Older Men With Obesity and Hypogonadism. The Journal of Clinical Endocrinology & Metabolism 2024; doi: 10.1210/clinem/dgae249
|
| 4 |
Kasiani Papadimitriou, Athanasios C. Mousiolis, Gesthimani Mintziori, Christina Tarenidou, Stergios A. Polyzos, Dimitrios G. Goulis. Hypogonadism and nonalcoholic fatty liver disease. Endocrine 2024; 86(1): 28 doi: 10.1007/s12020-024-03878-1
|
| 5 |
Alvile Kasarinaite, Matthew Sinton, Philippa T. K. Saunders, David C. Hay. The Influence of Sex Hormones in Liver Function and Disease. Cells 2023; 12(12): 1604 doi: 10.3390/cells12121604
|
| 6 |
Nicola Caretta, Raffaele Scafa, Andrea Graziani, Maria Cristina Crepaldi, Monica Vedovato, Angelo Avogaro, Alberto Ferlin. Noninvasive Indices of MASLD Are Associated With Hypogonadism in Male Patients With Type 2 Diabetes Mellitus. The Journal of Clinical Endocrinology & Metabolism 2024; 109(2): e522 doi: 10.1210/clinem/dgad586
|
| 7 |
Alessandro Cherubini, Sara Della Torre, Serena Pelusi, Luca Valenti. Sexual dimorphism of metabolic dysfunction-associated steatotic liver disease. Trends in Molecular Medicine 2024; doi: 10.1016/j.molmed.2024.05.013
|
| 8 |
Chia-Chu Liu, Shu-Pin Huang, Yung-Chin Lee, Cheng-Hsueh Lee, Tsung-Yi Huang, Jiun-Hung Geng, Che-Wei Chang, Chung-Yu Lin, Yung-Shun Juan, Wen-Jeng Wu, Tusty-Jiuan Hsieh. Metabolic dysfunction-associated fatty liver disease is an early predictor for testosterone deficiency in aging men without metabolic syndrome. Frontiers in Endocrinology 2023; 14 doi: 10.3389/fendo.2023.1252774
|
| 9 |
Ashley S. Meakin, Peter W. Nathanielsz, Cun Li, Vicki L. Clifton, Michael D. Wiese, Janna L. Morrison. Maternal obesity impacts fetal liver androgen signalling in a sex-specific manner. Life Sciences 2024; 337: 122344 doi: 10.1016/j.lfs.2023.122344
|
| 10 |
Ziteng Zhang, Chi Chen, Yuying Wang, Ningjian Wang, Yi Chen, Yingli Lu, Fangzhen Xia. The associations of total testosterone with probable nonalcoholic steatohepatitis and nonalcoholic fatty liver disease fibrotic progression in men with type 2 diabetes: a cross-sectional study. European Journal of Medical Research 2022; 27(1) doi: 10.1186/s40001-022-00958-8
|
| 11 |
Ross Apostolov, Darren Wong, Elizabeth Low, Karl Vaz, Jessica Spurio, Thomas Worland, Dorothy Liu, Roseanne Kimberley Chan, Paul Gow, Mathis Grossmann, Marie Sinclair. Testosterone is lower in men with non-alcoholic fatty liver disease and alcohol-related cirrhosis and is associated with adverse clinical outcomes. Scandinavian Journal of Gastroenterology 2023; 58(11): 1328 doi: 10.1080/00365521.2023.2220857
|
| 12 |
Elena Gangitano, Francesca Scannapieco, Carla Lubrano, Lucio Gnessi. Metabolic Syndrome, Hepatic Steatosis and Testosterone: A Matter of Sex. Livers 2024; 4(4): 534 doi: 10.3390/livers4040038
|
| 13 |
Hae Seung Lee, Sang Hun Han, Ronald Swerdloff, Youngju Pak, Matthew Budoff, Christina Wang. The Effect of Testosterone Replacement Therapy on Nonalcoholic Fatty Liver Disease in Older Hypogonadal Men. The Journal of Clinical Endocrinology & Metabolism 2024; 109(2): e757 doi: 10.1210/clinem/dgad511
|